Pharmacodynamics and Pharmacokinetics of HSK3486, a Novel 2,6-Disubstituted Phenol Derivative as a General Anesthetic
Top Cited Papers
Open Access
- 3 February 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 13, 830791
Abstract
Background: The purpose of this study was to characterize the novel sedative/hypnotic agent HSK3486, a 2,6-disubstituted alkylphenol analogue.Methods: The mechanism of action of HSK3486 was studied in competitive binding assays and whole-cell patch clamp assays. HSK3486 was administered by bolus intravenous injection to dogs and rats, and the loss of righting reflex as well as effects on the cardiovascular and respiratory systems were assessed. The in vitro metabolism of HSK3486 was analyzed by CYP450 genotyping and enzyme inhibition.Results: HSK3486 competed with t-butylbicycloorthobenzoate (TBOB) and t-butylbicyclophosphorothionate (TBPS) for binding to the gamma-aminobutyric acid type A (GABAA) receptor. HSK3486 potentiated GABA-evoked chloride currents at lower concentrations while activating GABAA receptor at higher concentrations. HSK3486 induced hypnosis in rats and dogs, and had a higher therapeutic index than propofol in rats. The hypnotic potency of HSK3486 was approximately 4-5 fold higher than that of propofol. HSK3486 exerted minimal effects on the cardiovascular system.Conclusions: HSK3486 is a positive allosteric regulator and direct agonist of GABAA receptor. It has a promising sedative/hypnotic effect and good in vivo pharmacokinetic properties, which justify further studies towards its clinical application.Keywords
This publication has 29 references indexed in Scilit:
- Analytic Reviews: Propofol Infusion Syndrome in the ICUJournal of Intensive Care Medicine, 2011
- The Incidence and Nature of Adverse Events During Pediatric Sedation/Anesthesia With Propofol for Procedures Outside the Operating Room: A Report From the Pediatric Sedation Research ConsortiumAnesthesia & Analgesia, 2009
- Mechanisms whereby Propofol Mediates Peripheral Vasolidation in HumansAnesthesiology, 1997
- Reducing Pain During Propofol InjectionAnesthesia & Analgesia, 1996
- Hemodynamic Changes During Induction of Anesthesia with Eltanolone and Propofol in DogsAnesthesia & Analgesia, 1995
- Negative Inotropic Effects of Propofol as Evaluated by the Regional Preload Recruitable Stroke Work Relationship in Chronically Instrumented DogsAnesthesiology, 1993
- Folates: epileptogenic effects and enhancing effects on [3H]TBOB binding to the GABAA-receptor complexEpilepsy Research, 1990
- Inhibition of retinoid toxicity by rat liver S9 fraction in cultured mammalian cellsCancer Letters, 1983
- Synthesis, biological evaluation, and preliminary structure-activity considerations of a series of alkylphenols as intravenous anesthetic agentsJournal of Medicinal Chemistry, 1980
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973